English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Radiotherapy (RT) is an important cancer treatment option, and is generally used in combination with other treatment alternatives, such as chemotherapy or tumor-removing surgery. Modern technology has allowed for the delivery of localized radiation to nearly every part of the body. However, normal tissue toxicity remains the most significant dose-limiting factor in clinical RT applications.[1] Radiation targets cellular DNA and can produce immediate cell death or loss of ability to sustain cell division.[2] In some cell types, cell death occurs rapidly, within several hours of irradiation.[3] This type of death, interphase death, is primarily limited to thymocytes, lymphocytes, spermatogonia, and other cells in rapidly proliferating tissue such

Effect of Radiotherapy Dose Rates on Early Intestinal Toxicity